Foamix

News

Israel's Foamix has said it is planning a US filing of its minocycline-based topical acne treatment after positive late stage trial results.

Oncology

At Reuters Pharma USA this week, Boehringer Ingelheim's Vicky Brown spoke with us about the company's recent approval for Hernexeos in NSCLC.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.